Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets
Diabetes · 2024
DOI: 10.2337/db23-0123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Julia Thorngren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Islets of Langerhans. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sigrid Juséliuksen Sätiö, Wellcome Trust, Insamlingsstiftelsen Diabetes Wellness Network Sverige.
Abstract (Originalsprache)
Pluripotent stem cell–derived islets (SC-islets) have emerged as a new source for β-cell replacement therapy. The function of human islet transplants is hampered by excessive cell death posttransplantation; contributing factors include inflammatory reactions, insufficient revascularization, and islet amyloid formation. However, there is a gap in knowledge of the engraftment process of SC-islets. In this experimental study, we investigated the engraftment capability of SC-islets at 3 months posttransplantation and observed that cell apoptosis rates were lower but vascular density was similar in SC-islets compared with human islets. Whereas the human islet transplant vascular structures were a mixture of remnant donor endothelium and ingrowing blood vessels, the SC-islets contained ingrowing blood vessels only. Oxygenation in the SC-islet grafts was twice as high as that in the corresponding grafts of human islets, suggesting better vascular functionality. Similar to the blood vessel ingrowth, reinnervation of the SC-islets was four- to fivefold higher than that of the human islets. Both SC-islets and human islets contained amyloid at 1 and 3 months posttransplantation. We conclude that the vascular and neural engraftment of SC-islets are superior to those of human islets, but grafts of both origins develop amyloid, with potential long-term consequences. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
- Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Joey Lau
Förderung
- Sigrid Juséliuksen Sätiö
- Wellcome Trust
- Insamlingsstiftelsen Diabetes Wellness Network Sverige
- Familjen Erling-Perssons Stiftelse
- Swedish Research Council
- Barndiabetesfonden
- The Academy of Finland
- Stiftelsen Familjen Ernfors Fond
Zitieren
APA
Thorngren, J., Brboric, A., Vasylovska, S., Hjelmqvist, D., Westermark, G. T., Saarimäki-Vire, J., Kvist, J., Balboa, D., Otonkoski, T., Carlsson, P. O., & Lau, J. (2024). Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets. Diabetes. https://doi.org/10.2337/db23-0123
Vancouver
Thorngren J, Brboric A, Vasylovska S, Hjelmqvist D, Westermark GT, Saarimäki-Vire J, et al. Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets. Diabetes. 2024. doi:10.2337/db23-0123
BibTeX
@article{Thorngren2024,
author = {Thorngren, Julia and Brboric, Anja and Vasylovska, Svitlana and Hjelmqvist, Daisy and Westermark, Gunilla T and Saarimäki-Vire, Jonna and Kvist, Jouni and Balboa, Diego and Otonkoski, Timo and Carlsson, Per-Ola and Lau, Joey},
title = {Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0123}
}
EUVIMED